M. Levi

Hematology · Circulation · 2001–2021

A researcher in the Science corpus: 14 papers; trusts 4 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom M. Levi trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. S. Coughlin
  2. Peter Libby
  3. Zaverio M. Ruggeri
  4. S. Weinbaum

Who trusts M. Levi overall

  1. A. Nurden
  2. R. Aftab

Papers from M. Levi's perspective

Ordered by how strongly the researchers M. Levi trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Clinical Characteristics of Coronavirus Disease 2019 in China (Journal of Emergency Medicine)
  2. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series (New England Journal of Medicine)
  3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia (Journal of Thrombosis and Haemostasis)
  4. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy (Journal of Thrombosis and Haemostasis)
  5. Laboratory haemostasis monitoring in COVID‐19 (Journal of Thrombosis and Haemostasis)
  6. Efficacy and safety of recombinant human activated protein C for severe sepsis. (New England Journal of Medicine)
  7. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. (Blood)
  8. Mechanotransduction and flow across the endothelial glycocalyx (Proceedings of the National Academy of Sciences of the United States of America)
  9. Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation. (Blood)
  10. Dysfunction of endothelial protein C activation in severe meningococcal sepsis. (New England Journal of Medicine)

Their papers